Shining Forward
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Shining Forward
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Moving Your MedTech Forward
Eliomedica is a medical device strategy firm converging engineering, science-backed regulatory, and commercialization expertise to transform innovative technologies into products with compelling value propositions. We achieve this by creating multifaceted market entry strategies that align regulatory, development, and business milestones.
We are technology enabled, leveraging Nyquist AI global intelligence platform with clinical, regulatory and medical device data.
Regulatory Affairs
Product-Market Fit Strategy
Product-Market Fit Strategy
- Strategy and roadmapping
- Pre-submissions and submissions
- FDA communications
- Design History Files (DHF)
Product-Market Fit Strategy
Product-Market Fit Strategy
Product-Market Fit Strategy
- Market landscape analysis
- Value proposition development
- Validation and sales strategy
- Reimbursement strategy
Research & Development
Product-Market Fit Strategy
Research & Development
- Concept studies
- Scientific and technical evaluation
- Pre-clinical and clinical strategies
- Usability studies
Systems Engineering
Systems Engineering
Research & Development
- Requirements & risks management
- Verification & validation strategy
- Design controls & traceability
Investor Relations
Systems Engineering
Investor Relations
- Funding strategy & pitch dev
- Introductions & communications
- Due diligence & negotiation
Roadmapping
Systems Engineering
Investor Relations
- Concept to launch
- Go-to-market
- Cross-functional alignment
We will be Your Advocate
Agility, adaptive service, strategic thinking and long term partnerships— these are our promises. Unlike larger consulting firms, our size allows us to offer a more intimate and hands-on approach, ensuring that every project receives the dedicated attention it deserves. Connect with us in Toronto or California to prepare for a successful launch.
Early stage to VC-backed startups
Spin-offs from large organizations
Physician entrepreneurs
MedTech investment firms
Hospital innovation hubs
Arash Samimi, PhD
Parth Agarwal, MBA
Parth Agarwal, MBA
Founder & Managing Partner
Market Entry Strategy
Highlights:
Ecosystem Partner, EEE Corp Group
Business Dev, StarFish Medical
Systems Eng, Synaptive Medical
Parth Agarwal, MBA
Parth Agarwal, MBA
Parth Agarwal, MBA
Partner
Sales & Go-to-Market Strategy
Highlights:
Business Dev & Investor, MediPines
Business Dev & investor, Pramptex
Golnaz Moeini, RAC
Parth Agarwal, MBA
Golnaz Moeini, RAC
Sr Consultant
Regulatory Strategy
Highlights:
Founder, MedEdge Regulatory
Director at Arterys, RA at Stryker
Emily Hayhurst
Parth Agarwal, MBA
Golnaz Moeini, RAC
Consultant
Design & Communications Strategy
Highlights:
Human Factors Eng, StarFish Medical
Design Researcher, SleepLabs
T. David Pyron
Francis Jeanson, PhD
Francis Jeanson, PhD
Sr Consultant
Product Development Strategy
Highlights:
Program Mgr, StarFish Medical
Director, Seaspan
Francis Jeanson, PhD
Francis Jeanson, PhD
Francis Jeanson, PhD
Advisor
Health Data & AI Strategy
Highlights:
Head, Ontario Brain Institute
Director, UHN
Golddy Kaur
Francis Jeanson, PhD
Golddy Kaur
Advisor
Regulatory & Business Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
Through the Eyes of our Clients
ElioMedica has been an invaluable partner for NovaTechs, offering exceptional regulatory consulting with a unique blend of expertise, deep knowledge, and an innovative approach. Their method not only supports startups like ours in navigating complex regulatory landscapes but also empowers us to learn and implement regulatory practices effectively. I genuinely look forward to our meetings with ElioMedica - a rare sentiment for regulatory discussions - because of the passion and insight they bring to the table. Each interaction is an opportunity to grow, and their dedication to fostering understanding makes the process both engaging and educational. I wholeheartedly recommend ElioMedica to anyone seeking a partner who combines technical excellence with a collaborative and inspiring approach.
Mohammad Nasiri, PhD
Founder & CEO, NovaTechs
---
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
Dr. Anya McLaren-Barnett, MD
Founder, The Sleep Health Organization
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
Founder & CEO, Deep Breathe AI
Our Community Partners
